BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 338644)

  • 1. Pharmacokinetics of iodamide in normal subjects and in patients with renal impairment.
    Difazio LT; Singhvi SM; Heald AF; McKinstry DN; Brosman SA; Gillenwater JY; Willard DA
    J Clin Pharmacol; 1978 Jan; 18(1):35-41. PubMed ID: 338644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal handling of iodamide and diatrizoate. Evidence of active tubular secretion of iodamide.
    Bollerup AC; Hesse B; Steiness E
    Eur J Clin Pharmacol; 1975 Oct; 9(1):63-7. PubMed ID: 1233254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distribution and excretion of iodamide-380 determined by roentgen fluorescence analysis].
    Zajcik VE; Amosov IS; Frolova EI; Jakovlev VJa
    Radiol Diagn (Berl); 1983; 24(3):429-34. PubMed ID: 6611913
    [No Abstract]   [Full Text] [Related]  

  • 4. Drip infusion urography with meglumine iodamide.
    Robbins AH; Rosenfield AT; Pizzolato NF; Irwin GA; Putman CE; Gerzof SG; Ulreich S
    AJR Am J Roentgenol; 1978 Dec; 131(6):1043-6. PubMed ID: 104570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between iodamide and iothalamate in intravenous urography.
    Dubbins PA; Marshall W; O'Riordan D; O'Neill G; Ruffell E; Laws JW
    Clin Radiol; 1981 Nov; 32(6):677-8. PubMed ID: 7307439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of cimetidine on the renal excretion of verografin and iodamide in dogs].
    Ul'ianov GP
    Eksp Klin Farmakol; 1994; 57(6):53-4. PubMed ID: 7756965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid determination of renal contrast media in biological fluids by means of high-performance liquid chromatography.
    Hekman P; Van Ginneken CA
    J Chromatogr; 1980 Jun; 182(3-4):492-5. PubMed ID: 7391196
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of the sodium salts of iodamide and iothalamate in clinical urography.
    Owen JP; Keir MJ; Lamballe AK; Laker MF; Fitzjohn TP; Wilsdon JB; Murray A; Campbell RW
    Clin Radiol; 1983 May; 34(3):353-7. PubMed ID: 6839661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The renal transport of cardiotrast, verografin and iodamide].
    Ul'ianov GP; Lampatov VV
    Farmakol Toksikol; 1990; 53(1):62-4. PubMed ID: 2328806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-medium-induced electrocardiographic abnormalities: comparison of bolus and infusion of methylglucamine iodamide and methylglucamine/sodium diatrizoate.
    Pfister RC; Hutter AM; Newhouse JH; Yoder IC; Travers E
    AJR Am J Roentgenol; 1983 Jan; 140(1):149-53. PubMed ID: 6600306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of meglumine iodamide and Renografin-60 for excretory urography.
    Gerzof SG; Robbins AH; Unger G; Zaki A; Wickis EA
    AJR Am J Roentgenol; 1977 Feb; 128(2):211-5. PubMed ID: 401604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the methylglucamine salts of iodamide and iothalamate in clinical urography.
    Owen JP; Keir MJ; Nair KV; Lauckner D; Wilsdon JB
    Clin Radiol; 1981 May; 32(3):341-6. PubMed ID: 7237916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ceftezole in patients with normal and impaired renal function.
    Ohkawa M; Kuroda K
    Chemotherapy; 1980; 26(4):242-7. PubMed ID: 7389424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
    Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [X-ray method of determining the rate of iodamide absorption from the peritoneal cavity].
    Sviridov NK
    Eksp Khir Anesteziol; 1976; (6):46-8. PubMed ID: 1022498
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
    Jungheinrich C; Scharpf R; Wargenau M; Bepperling F; Baron JF
    Anesth Analg; 2002 Sep; 95(3):544-51, table of contents. PubMed ID: 12198032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of iodamide and diatrizoate for excretory urography.
    Rosenfield AT; Putman CE; Ulreich S; Koss N
    Yale J Biol Med; 1977; 50(6):631-6. PubMed ID: 345632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urography with iohexol. Comparison with metrizoate and iodamide.
    Edgren J; Kivisaari A; Laasonen L; Standertskiƶld-Nordenstam CG
    Acta Radiol Suppl; 1983; 366():46-9. PubMed ID: 6382934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous erythromycin.
    Welling PG; Craig WA
    J Pharm Sci; 1978 Aug; 67(8):1057-9. PubMed ID: 671237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.